Axsome Therapeutics Initiates CLARITY Phase 3 Trial of Solriamfetol in Adults with Major Depressive Disorder with Excessive Daytime Sleepiness Symptoms

CLARITY (Clinical Assessment of Response in the Treatment of Depression with Daytime Sleepiness Using Solriamfetol) is a Phase 3, double-blind, placebo-controlled, multicenter randomized withdrawal ...
Zacks Investment Research on MSN

AXSM Q4 loss wider than expected, revenues surge Y/Y on Auvelity sales

Axsome Therapeutics AXSM incurred a loss of 71 cents per share in the fourth quarter of 2025, wider than the Zacks Consensus Estimate of a loss of 70 cents. The company had incurred a loss of 96 cents ...
Psychology Today

Eating Disorders in Athletes Are More Common Than You Think

Eating disorders in athletes are common-yet sometimes missed. The outcomes of this can be dire. Here's what to know and what ...

Kerry Washington shares about life with an eating disorder: ‘When I’m in recovery, my disease is outside, doing push-ups’

Kerry Washington, who has struggled with an eating disorder for much of her adult life, opens up about her lifelong ...
Good Morning America

Kerry Washington says eating disorders don't always look the way we think

Because outdated stereotypes can delay diagnosis, Washington said that eating disorders should be viewed through a broader lens that includes biology, psychology, and social influences.